ETOH
OPIOIDS
TOBACCO
Potpourri
100

The most widespread self-help group for Alcohol Use Disorder is called

Alcoholics Anonymous


100

codeine and morphine are examples of ____.

Opium – dried sap from the opium poppy (Papaver somniferum) 

Opiates – alkaloids found in the opium poppy (e.g., codeine, morphine) 

Opioids – compounds with opiate-like actions (e.g., endogenous endorphins, heroin, prescription pain medications

100

TRUE OR FALSE: there are now more former smokers than current smokers

TRUE!

100

Effects of naloxone on patients without opioids in their system?

None. It is safe to use even if unsure if patient had an opioid overdose.

200

Gold standard rating scale to assess status of AUD

CAGE: Cut down, Annoyed, Guilty, Eye-opener

or 

Alcohol Use Disorders Identification Test (AUDIT)

200

First-line pharmacotherapy for opioid dependence

methadone  
buprenorphine/naloxone

200

On average, _____ attempts are necessary for a patient to quit successfully

7

200

What is the most commonly abused illict drug?

Marijuana - it is still illegal at the federal level regardless of state regulations/laws

300

Cofactor depleted d/t altered GI absorption/poor diet. may lead to Wernicke's encephalopathy and Korsakoff Syndrome 

thiamine. 



300

MOA of buprenorphine 

partial agonist at the opioid mu receptor and an antagonist of the kappa receptor. T

300

The five R’s can increase motivation to quit:  

relevance, risks, rewards, roadblocks, and repetition.

300

For pts on opioid therapy, at what point are they most at risk for an OD?  

Risks for opioid overdose are greatest during the first 3-7 days after opioid initiation or an increase in dosage, particularly when ER/LA opioids are initiated. 


400

Indirect Biomarkers for AUD 

Ratio AST:ALT >2:1 suggests liver damage from alcohol. ALT less sensitive than AST 

GGT: Enzyme that increases after weeks to months of heavy alcohol consumption. high sensitivty. potential false positive. 


400

MOA of methadone 

full opioid receptor agonist

400

true or false: Varenicline can be combined w/ nicotine patch and buprenorphine

TRUE.  Combining varenicline with nicotine replacement therapy may increase adverse effects, though varenicline has been used in combination with the nicotine patch. Varenicline can be combined with bupropion. 

400

When do DT's start?

3-5 days after last drink

500

Direct Biomarkers for AUD
     **DAILY DOUBLE**

Ethyl glucuronid: urine-based biomarker. Indicator that alcohol ingestion has occurred in the last 3-4 days Commonly used in zero tolerance or abstinence-based program

phosphatidyl ethanol: serum-based biomarker; linear dose-response relationship; more research is warranted  

500

When can methadone be dispensed from a pharmacy?


When prescribed for pain. Inpatient use has different rules/regulations

500

The maximum number of pieces of nicotine gum is ___ pieces in 24 hours.

24

500

half life of methadone (chronic use)

With ongoing dosing, the half life of methadone is extended to between 13 and 47 hours with a mean of 24 hours.

600

First-line pharmacotherapy for AUD

either naltrexone or acamprosate, unless there is a patient-specific reason to begin with disulfiram


American Psychiatric Intervention First-line
Association (APA) (2006, 2018)

600

Length of recommended abstinence prior to initiation of naltrexone.

What is 7-10 days for short-acting opioids and 10-14 days for long-acting?

600

The maximum number of pieces of nicotine lozenge is ___ pieces in 24 hours.

20

600

TRUE OR FALSE: CYP 3A4 inhibitors decrease buprenorphine exposure

FALSE

700

Contraindications of Naltrexone 

-opioid use within the last 7-10 days (potentially longer if using long-acting opioids, i.e., buprenorphine or methadone within the last 14 days)
-acute opioid withdrawal
-failure of a naloxone challenge
-history of hypersensitivity to naltrexone or other product ingredients
-acute hepatitis, severe hepatic impairment (LFTs greater than 3 times the upper limit of normal)

700

Prescribing consideration for buprenorphine for outpatient setting

X-waiver: Qualifying practitioners need 8 hours of training while qualifying other practitioners need an additional 16 hours.

DEA X# Inpatient has different rules/regulations



700

Varenicline MOA

A nicotine receptor partial agonist. Varenicline blocks the effects of nicotine from smoking . (nicotine is full agonist)

700

explain how naloxone works as an abuse deterrent in buprenorphine/naloxone.

naloxone is more rapidly inactivated after oral/ sublingual absorption than parenteral administration

800

Dosing of Acamprosate

666mg TID

800

Prescribing consideration for methadone

Can be used to treat OUD only via accredited opioid treatment programs (OTP).


42 in VA w/ 1 in Roanaoke.

800

BBW for Varenicline

neuropsychiatric symptoms, including depression, suicidal ideation, suicide, psychosis, mood disturbance, and hostility

800

buprenorphine's MOA  allows patients enough effect to “feel normal” but minimizes functional impairment, which is something referred to as the__________.

the ceiling effect

900

Duration of time for ALDH concentrations to return to baseline after disulfiram discontinuation.

~14 days

900

Treatment with buprenorphine involves what three phases

induction, stabilization and maintenance phase 

900

Bupropion SR should be initiated ____. 

7 days before quit date. Treatment should last for at least 8 weeks but can be continued for up to 6 months to increase chances of quitting

900

Clinical drinking outcomes with acamprosate?

decreased in heavy drinking days, decreased cravings

1000

Antiepileptics recommended as 2nd line tx 

Topiramate has been associated with decreases in heavy drinking days and drinking days overall

Gabapentin has been shown to reduce heavy drinking days and increase abstinence rates


1000

If IV drug use is identified, this should be offered to vets.

pre-exposure prophylaxis (PrEP

Tenofovir disoproxil fumarate-emtricitabine

1000

For patients who smoke more than 10 cigarettes/day, patch schedule 

21 mg/day for 2 weeks, then 14 mg/day for 2 weeks, then 7 mg/day for 2 weeks

1000

MOA of lofexidine

Lofexidine is a central alpha-2 adrenergic agonist that reduces the release of norepinephrine and decreases sympathetic tone

M
e
n
u